Literature DB >> 13424652

Experimental cryptococcosis (torulosis).

S LEVINE, H M ZIMMERMAN, A SCORZA.   

Abstract

Entities:  

Keywords:  CRYPTOCOCCOSIS/experimental

Mesh:

Year:  1957        PMID: 13424652      PMCID: PMC1934692     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  8 in total

1.  Torulosis of the skin.

Authors:  Y BUREAU; H BARRIERE; R TRICHEREAU
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1955 Sep-Oct

2.  Torulosis; a case mimicking Hodgkin's disease and rodent ulcer and a presumed case of pulmonary torulosis with acute dissemination.

Authors:  W S SYMMERS
Journal:  Lancet       Date:  1953-11-21       Impact factor: 79.321

3.  Pulmonary cryptococcosis.

Authors:  I H LINDEN; C G STEFFEN
Journal:  Am Rev Tuberc       Date:  1954-01

4.  Occurrence of Cryptococcosis in patients with malignant disease of reticuloendothelial system.

Authors:  L E ZIMMERMAN; H RAPPAPORT
Journal:  Am J Clin Pathol       Date:  1954-09       Impact factor: 2.493

5.  Studies of the cortisone effects on the inflammatory response. 1. Alterations of the histopathology of chemically induced inflammation.

Authors:  D M SPAIN; N MOLOMUT; A HABER
Journal:  J Lab Clin Med       Date:  1952-03

6.  Cortisone and roentgen radiation in combination as synergistic agents for production of lethal infections.

Authors:  J T SYVERTON; A A WERDER; J FRIEDMAN; F J ROTH; A B GRAHAM; O J MIRA
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

7.  A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica).

Authors:  J M NEILL; I ABRAHAMS; C E KAPROS
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

8.  XII. Blastomycosis of the Spine: Double Lesion: Two Operations: Recovery.

Authors:  G E Brewer; F C Wood
Journal:  Ann Surg       Date:  1908-12       Impact factor: 12.969

  8 in total
  11 in total

1.  The influence of cortisone on experimental fungus infections in mice.

Authors:  D B LOURIA; N FALLON; H G BROWNE
Journal:  J Clin Invest       Date:  1960-09       Impact factor: 14.808

2.  Histology of experimental murine cryptococcosis.

Authors:  G FAZEKAS; J SCHWARZ
Journal:  Am J Pathol       Date:  1958 May-Jun       Impact factor: 4.307

Review 3.  Experimentally induced immunity in the mycoses.

Authors:  Y C Kong; H B Levine
Journal:  Bacteriol Rev       Date:  1967-03

4.  Cryptococcal meningitis associated with steroid therapy.

Authors:  T S Wilson; W A Fleming; F L Robinson; B Nicholl
Journal:  J Clin Pathol       Date:  1970-11       Impact factor: 3.411

5.  Studies on organ specificity in experimental murine cryptococcosis.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1981-12-11       Impact factor: 2.574

6.  Experimental cutaneous primary infection with Cryptococcus neoformans (Sanfelice) Vuillemin.

Authors:  K K Sethi; K Salfelder; J Schwarz
Journal:  Mycopathol Mycol Appl       Date:  1965-12-01

7.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.

Authors:  M A Dykstra; L Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Studies on relationship between cysts and granulomas in murine cryptococcosis.

Authors:  T Watabe; M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1984-05-30       Impact factor: 2.574

10.  Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.

Authors:  S A Moser; F L Lyon; J E Domer; J E Williams
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.